Radcliffe Capital Management, L.P. Da32 Life Science Tech Acquisition Corp. Transaction History

Radcliffe Capital Management, L.P.

  • $4.34 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$9.65 - $9.83 $184,141 - $187,576
19,082 Added 13.06%
165,205 $1.6 Million
Q1 2022

May 16, 2022
BUY
$9.59 - $9.81 $1.4 Million - $1.43 Million
146,123 New
146,123 $1.42 Million

About DA32 Life Science Tech Acquisition Corp.

DALS Quotes by TradingView
  • Ticker DALS
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,650,000
  • Description
  • DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...
More about DALS
Track This Portfolio

Track Radcliffe Capital Management, L.P. Portfolio

Follow Radcliffe Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radcliffe Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Radcliffe Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email